Literature DB >> 7966657

Outcome analysis of 42 cases of renal angiomyolipoma.

M J Kennelly1, H B Grossman, K J Cho.   

Abstract

Angiomyolipomas were found in 42 kidneys in 23 female and 8 male patients at our medical center. Angiomyolipoma was diagnosed by computerized tomography (CT) alone in 55% of the cases, and by a combination of ultrasound and CT in 36%. Nine of 11 patients with bilateral angiomyolipoma had associated tuberous sclerosis. Treatment consisted of observation in 22 patients, selective arterial embolization in 6, partial nephrectomy in 6 and nephrectomy in 8. A total of 17 patients who were observed had tumors smaller than 4 cm. and 4 h had angiomyolipoma of 4 to 10 cm. With a mean followup of 3.8 years, no observation patient had subsequent renal hemorrhage and only 1 (tumor larger than 10 cm.) had radiographic progression. Despite progression, the latter patient remained asymptomatic for 18 years. Selective arterial embolization (3 tumors 4 to 10 cm. and 3 larger than 10 cm.) resulted in preservation of renal function at a mean of 1 year. All patients treated with partial nephrectomy (6 tumors 4 to 10 cm.) maintained stable renal function without recurrence during a mean 4.7-year followup. Similarly, all individuals who underwent nephrectomy (4 tumors smaller than 4 cm., 3 tumors 4 to 10 cm. and 1 tumor larger than 10 cm.) have stable renal function. We recommend renal conservation for patients with renal angiomyolipoma using a strategy of observation for small asymptomatic tumors, partial nephrectomy for moderate size tumors and selective arterial embolization of large tumors not amenable to partial nephrectomy.

Entities:  

Mesh:

Year:  1994        PMID: 7966657     DOI: 10.1016/s0022-5347(17)32286-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  Life threatening hematuria in a patient with renal angiomyolipoma and selective renal embolization prior to nephrectomy.

Authors:  Cem Ozden Yeniyol; Nuri Zeyrek; Mustafa Parildar; Elif Selek; Funda Taşli; Ahmet Memiş
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 3.  Tuberous sclerosis complex presenting as bilateral large renal angiomyolipomas.

Authors:  Neelam Redkar; Meenakshi Amit Patil; Tushar Dhakate; Prasad Kolhe
Journal:  BMJ Case Rep       Date:  2012-08-08

4.  Renal angiomyolipoma with malignant transformation, simultaneous occurrence with malignity and other complex clinical situations.

Authors:  Osman Inci; Mustafa Kaplan; Omer Yalcin; Irfan Huseyin Atakan; Huseyin Kubat
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 5.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

Review 6.  Clinical and molecular insights into tuberous sclerosis complex renal disease.

Authors:  Brian J Siroky; Hong Yin; John J Bissler
Journal:  Pediatr Nephrol       Date:  2010-12-09       Impact factor: 3.714

Review 7.  Tuberous sclerosis complex: neurological, renal and pulmonary manifestations.

Authors:  D N Franz; J J Bissler; F X McCormack
Journal:  Neuropediatrics       Date:  2011-01-05       Impact factor: 1.947

8.  Transcatheter embolisation of renal angiomyolipoma.

Authors:  S Leong; A N Keeling; F P McGrath; M J Lee
Journal:  Ir J Med Sci       Date:  2009-07-18       Impact factor: 1.568

Review 9.  Renal Tumors of Childhood: Radiologic-Pathologic Correlation Part 2. The 2nd Decade: From the Radiologic Pathology Archives.

Authors:  Ellen M Chung; Grant E Lattin; Kimberly E Fagen; Andrew M Kim; Michael A Pavio; Adam J Fehringer; Richard M Conran
Journal:  Radiographics       Date:  2017 Sep-Oct       Impact factor: 5.333

Review 10.  MRI of the kidney-state of the art.

Authors:  J J Nikken; G P Krestin
Journal:  Eur Radiol       Date:  2007-07-24       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.